Trial Profile
A retrospective study to evaluate the efficacy, safety and pharmacokinetic of raltegravir and atazanavir dual therapy in adult HIV-infected patients
Status:
Completed
Phase of Trial:
Phase II
Latest Information Update: 02 Mar 2016
Price :
$35
*
At a glance
- Drugs Atazanavir (Primary) ; Raltegravir (Primary) ; Ritonavir
- Indications HIV infections; HIV-1 infections
- Focus Adverse reactions; Therapeutic Use
- 02 Mar 2016 New trial record